Conditions: Esophageal Cancer
Intervention Type: Drug
Intervention Name: irinotecan hydrochloride
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "irinotecan hydrochloride" on "Esophageal Cancer".
-
Phase II Trial of Cisplatin and Irinotecan in Patients With Advanced Esophageal Cancer
NCTID: NCT00003055
-
A Phase II Study of Taxotere and Irinotecan (CPT-11) in Patients With Advanced Adenocarcinoma of the Lower Esophagus, Esophagogastric Junction, and Gastric Cardia
NCTID: NCT00004235
-
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
NCTID: NCT00003137
-
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
NCTID: NCT00003748
-
Phase II Single-Arm Trial Of CPT-11 (Irinotecan HC1; Camptosar Injection)/Cisplatin In Patients With Advanced Esophageal Cancer
NCTID: NCT00030862
-
Gemcitabine Plus Irinotecan in Patients With Esophageal Cancer, Phase II
NCTID: NCT00012363